Collegium Pharmaceutical Stock (NASDAQ: COLL) stock price, news, charts, stock research, profile.
Open | $35.830 |
Close | - |
Volume / Avg. | 8.105K / 407.717K |
Day Range | 35.690 - 36.020 |
52 Wk Range | 20.830 - 40.950 |
Market Cap | $1.173B |
P/E Ratio | 27.860 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 26.89% |
Days to Cover | 14.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Collegium Pharmaceutical (NASDAQ: COLL) through any online brokerage.
Other companies in Collegium Pharmaceutical’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and Neumora Therapeutics (NASDAQ:NMRA).
The latest price target for Collegium Pharmaceutical (NASDAQ: COLL) was reported by Needham on Thursday, April 11, 2024. The analyst firm set a price target for 40.00 expecting COLL to rise to within 12 months (a possible 11.27% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Collegium Pharmaceutical (NASDAQ: COLL) is $35.95 last updated Today at April 24, 2024 at 10:07 AM EDT.
There are no upcoming dividends for Collegium Pharmaceutical.
Collegium Pharmaceutical’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Collegium Pharmaceutical.
Collegium Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.